NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Eris Lifesciences Limited (NSE: ERIS)
ERIS Technical Analysis
5
As on 28th Mar 2025 ERIS SHARE Price closed @ 1417.35 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1217.26 & Strong Buy for SHORT-TERM with Stoploss of 1281.06 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ERISSHARE Price
Open | 1405.00 | Change | Price | % |
High | 1425.00 | 1 Day | 11.90 | 0.85 |
Low | 1388.40 | 1 Week | 26.45 | 1.90 |
Close | 1417.35 | 1 Month | 234.55 | 19.83 |
Volume | 86566 | 1 Year | 574.00 | 68.06 |
52 Week High 1206.05 | 52 Week Low 567.95 |
NSE INDIA Most Active Stocks
IDEA | 6.80 | -1.73% |
YESBANK | 16.88 | -2.20% |
RPOWER | 42.98 | 0.02% |
ZOMATO | 201.70 | -2.22% |
NHPC | 82.20 | 1.13% |
CGCL | 170.21 | 3.22% |
GTLINFRA | 1.40 | -1.41% |
IDFCFIRSTB | 54.96 | -3.48% |
IOB | 38.97 | -6.66% |
SUZLON | 56.66 | -0.61% |
NSE INDIA Top Gainers Stocks
NSE INDIA Top Losers Stocks
ERIS Daily Charts |
ERIS Intraday Charts |
Whats New @ Bazaartrend |
ERIS Free Analysis |
|
ERIS Important Levels Intraday
RESISTANCE | 1487.88 |
RESISTANCE | 1465.26 |
RESISTANCE | 1451.28 |
RESISTANCE | 1437.30 |
SUPPORT | 1397.40 |
SUPPORT | 1383.42 |
SUPPORT | 1369.44 |
SUPPORT | 1346.82 |
ERIS Target March 2025
4th UP Target | 2118.81 |
3rd UP Target | 1833.14 |
2nd UP Target | 1656.56 |
1st UP Target | 1479.98 |
1st DOWN Target | 976.12 |
2nd DOWN Target | 799.54 |
3rd DOWN Target | 622.96 |
4th DOWN Target | 337.29 |
ERIS Weekly Target
4th UP Target | 1918.90 |
3rd UP Target | 1749.57 |
2nd UP Target | 1644.90 |
1st UP Target | 1540.23 |
1st DOWN Target | 1241.57 |
2nd DOWN Target | 1136.90 |
3rd DOWN Target | 1032.23 |
4th DOWN Target | 862.90 |
ERIS Target2025
4th UP Target | 2895.84 |
3rd UP Target | 2407.68 |
2nd UP Target | 2105.94 |
1st UP Target | 1804.2 |
1st DOWN Target | 943.2 |
2nd DOWN Target | 641.46 |
3rd DOWN Target | 339.72 |
4th DOWN Target | -148.44 |
Eris Lifesciences Limited ( NSE INDIA Symbol : ERIS )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
ERIS Synopsis Technicals View
50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
RSI (14) | RSI is Below 30 | Over Sold | |
MFI (14) | MFI is 22.44 | Sideways | |
CCI (20) | CCI is Below -100 | Over Sold | |
WILLIAM %R (14) | William %R is -47.38 | Sideways | |
ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
PSAR | Stoploss For Long Buy | 321.00 | |
10 Day Avg Volume | Traded 456.30 % More then 10 Day Average Volume |
ERIS Other Details
Segment | EQ | |
Market Capital | 0.00 | |
Sector | ||
Industry | ||
Offical website | > echo $website ; ?> |
ERIS Address
![]() |
ERIS Latest News
ERIS Business Profile
N/A
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service